XML 33 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities:    
Net loss $ (28,503) $ (20,309)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 6,306 6,965
Amortization of deferred financing costs and debt discount 8,511 5,762
Loss (gain) on sale of property, plant and equipment 210 (4)
Unrealized foreign currency gain (223) (784)
Noncash interest paid in kind 11,810 9,755
Noncash rent expense 544 0
Noncash compensation expense 1,715 2,063
Deferred income taxes (2,016) (4,188)
Other, net 0 463
Changes in assets and liabilities:    
Accounts receivable (8,356) (15,253)
Inventories 10,029 (14,324)
Prepaid expenses and other current assets 5,873 (3,614)
Other noncurrent assets (134) 540
Prepaid pension costs (566) (2,065)
Accounts payable 5,093 8,947
Income tax payable and receivable (1,805) (83)
Accrued and other current liabilities (3,451) 1,791
Lease liabilities (340)  
Pension and postretirement benefit obligations and other noncurrent liabilities (111) (287)
Net cash from (used in) operating activities 4,586 (24,625)
Investing activities:    
Capital expenditures (3,530) (4,909)
Proceeds from sale of property, plant and equipment 442 53
Net cash used in investing activities (3,088) (4,856)
Financing activities:    
Proceeds from long-term debt including credit facilities 3,500 45,454
Repayments of long-term debt including credit facilities (4,488) (17,600)
Repayments of short-term borrowings, net (1,238) (607)
Principal paid on financing leases (454)  
Payments of debt issue costs 0 (499)
Payments of build-to-suit liability 0 (897)
Net cash (used in) from financing activities (2,680) 25,851
Effect of exchange rate changes on cash and cash equivalents 13 (118)
Net change in cash and cash equivalents (1,169) (3,748)
Cash and cash equivalents - beginning of year 8,668 11,104
Cash and cash equivalents - end of period $ 7,499 $ 7,356